SCHEMBL3466524

SCHEMBL3466524

COC(=O)C(CCCc1ccccc1)CCc1ccc(-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 2/20 0.51
MMP2 P08253 5/20 0.50
MMP3 P08254 3/20 0.50
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
MGLL Q99685 1/20 0.44
PLAAT3 P53816 1/20 0.44
PLAAT5 Q96KN8 1/20 0.44
PLAAT2 Q9NWW9 1/20 0.44
PLAAT4 Q9UL19 1/20 0.44
FAAH O00519 1/20 0.43
SLC6A5 Q9Y345 1/20 0.43
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43
PPARD Q03181 1/20 0.43
PPARA Q07869 1/20 0.43
FFAR1 O14842 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1857332 0.91 LTA4H (0.52) FDFT1MMP2MMP3NOS3NOS1
SCHEMBL3467645 0.90 MMP2 (0.56) MMP2MMP3MGLLPPARDHDAC1
SCHEMBL1860059 0.89 MMP12 (0.53) FDFT1MMP2MMP3MMP12MMP13
SCHEMBL3466571 0.87 MMP2 (0.48) MMP2MMP3MMP12MMP13MMP1
SCHEMBL3467455 0.87 FDFT1 (0.56) FDFT1MMP2MMP3PLAAT3PLAAT5
SCHEMBL3466649 0.85 SLC13A5 (0.48) MMP2MMP3MMP13PPARAFFAR4
SCHEMBL1859940 0.85 GRIK1 (0.51) MMP2MMP3
SCHEMBL3467613 0.84 PPARA (0.50) FDFT1MMP2MMP3PLAAT3PLAAT5
SCHEMBL3467360 0.84 ALDH1A1 (0.54) MMP2MMP3PLAAT3PLAAT5PLAAT2
SCHEMBL1858600 0.82 GRIK1 (0.54) MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed